We consider ourselves very fortunate to have Spinelli join Geritrex's leadership team
Mount Vernon, NY (PRWEB) August 26, 2009
Geritrex, a privately held pharmaceutical company that offers affordable, high-quality healthcare products, is pleased to announce the appointment of William Spinelli as Vice President of Sales and Business Development for the corporation. Spinelli brings to the manufacturing organization a proven track record of increasing company revenues through well-planned and executed sales initiatives.
"We consider ourselves very fortunate to have Spinelli join Geritrex's leadership team," said Geritrex Corp.'s President and CEO, Anthony Madaio. "Our company has exhibited significant sales and profit growth over the course of 2009, and we believe Spinelli will play an integral role in maintaining our continued growth and success."
Spinelli has more than a decade of sales management experience in the healthcare sector, and has worked for esteemed pharmaceutical organizations including Bayer Healthcare Pharmaceuticals and Berlex Laboratories. In his role at Geritrex Corp., Spinelli will help introduce new healthcare products into the marketplace, manage the wholesale-distributor relationships, expand the company's private label business as well as augment the sales force.
Spinelli will be the primary point of contact for sales and account management of large, national accounts, and can be reached at 914-668-4003 Ext. 106 or wspinelli(at)geritrex(dot)com. General inquiries about product sales can be submitted to sales(at)geritrex(dot)com or to the company's headquarters at Geritrex Corp., 144 Kingsbridge Road East, Mount Vernon, NY 10550.
About Geritrex Corp.
For over 30 years, the Geritrex Corporation has been developing and producing a proprietary healthcare line, private label medical products and generic equivalents of brand name over-the-counter health items. The company's affordable, high-quality healthcare products are currently being distributed to hospitals, long-term care facilities and other institutions. To learn more about the company's current offerings, please visit http://www.geritrex.com.